Trust linked to Nuvalent (NUVL) files Form 144 to sell 1,650 shares
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Nuvalent, Inc. insider-related trust plans modest stock sale under Rule 144. A Form 144 notice reports that the Matthew Shair 2021 Irrevocable Trust intends to sell 1,650 shares of Nuvalent Class A common stock through J.P. Morgan Securities on Nasdaq, with an aggregate market value of 166,125. The notice states that 67,271,461 Class A shares were outstanding, providing context for the planned sale’s relative size. The shares to be sold were originally acquired by grant and transferred to the trust on 07/13/2021. The filing also lists several prior sales by the same trust over the past three months.
Positive
- None.
Negative
- None.
FAQ
Which broker and exchange are involved in the Nuvalent (NUVL) Form 144 sale?
The planned Rule 144 sale will be executed through J.P. Morgan Securities LLC as broker. The Class A common stock is expected to be sold on Nasdaq, which is the named securities exchange in the Form 144 disclosure for this transaction.
What representation does the seller make in the Nuvalent (NUVL) Form 144?
The person for whose account the shares are to be sold represents by signing that they do not know any undisclosed material adverse information about the issuer’s current or prospective operations, consistent with Rule 144 requirements stated in the notice’s certification language.